RecruitingNCT05562323

Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study

Sponsor

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Enrollment

100 participants

Start Date

Sep 14, 2022

Study Type

OBSERVATIONAL

Conditions

Monkeypox

Summary

This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is tracking how well the monkeypox (mpox) vaccine works in people who receive it — specifically measuring the immune responses it produces over time. Participants won't receive any experimental treatment; researchers will simply collect blood samples and follow up with participants after vaccination. **You may be eligible if...** - You are 18 years of age or older - You are willing to follow the study schedule and attend follow-up visits - You are able to give informed consent **You may NOT be eligible if...** - You have a medical condition or finding that your doctor believes would make participation unsafe or interfere with the study results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.